As a member of the GLP-1 receptor agonist class, Retatrutide imitates natural hormones responsible for regulating hunger and energy usage
Nevertheless, current evidence supports GLP-1 RAs and multi-agonist formulations as highly promising pharmacotherapies that address the complex, multifactorial pathophysiology of MASLD while simultaneously improving cardiometabolic comorbidities, positioning them as cornerstone treatments in the evolving therapeutic landscape for this prevalent and burdensome disease
Prescribing decisions should be individualized, grounded in a complete metabolic assessment (not just HbA1c), and aligned with the patient's goals and willingness to commit to sustained treatment
Semaglutide injection therapy can cause skin changes during rapid weight loss, and sun exposure requires extra caution
These vesicles act as intercellular communication mediators and can be analyzed as stable biomarkers in culture media [418, 425]
Dynamic measurement of disease activity in acute pancreatitis: the pancreatitis activity scoring system